SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-053031
Filing Date
2012-09-26
Accepted
2012-09-26 16:32:31
Documents
4
Period of Report
2012-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v324470_8k.htm 8-K 23326
2 EXHIBIT 10.1 v324470_ex10-1.htm EX-10.1 31262
3 EXHIBIT 99.1 v324470_ex99-1.htm EX-99.1 9910
4 GRAPHIC tlogo.jpg GRAPHIC 19063
  Complete submission text file 0001144204-12-053031.txt   92152
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 121111300
SIC: 2834 Pharmaceutical Preparations